INVO Fertility, Inc. (IVF)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NASDAQ
$1.11
-22.38%
Investingg Score
33.2 / 100
Sell
Business overview
- Gross margin of 99.6%
- Operating margin of -105.8%
- Financial Quality pillar score of 8
Although the company maintains exceptionally high gross margins, heavy operational overhead results in severe operating losses and a low quality score.
Financial health
- Free cash flow margin of -103.2%
- Balance Sheet pillar score of 46
- Financial Quality pillar score of 8
Deeply negative cash flow margins indicate persistent cash burn that limits the company's financial stability.
- Gross Margin
- 99.6%
- Operating Margin
- -105.8%
- Current Ratio
- 0.3x
- Debt / Equity
- 0.10
- Free Cash Flow (TTM)
- $-0.0B
- Interest Coverage
- -6x
Valuation
- Price-to-sales (P/S) ratio of 0.07
- Free cash flow yield of -1332%
- P/E and forward P/E ratios are unavailable (null)
- Valuation pillar score of 37
The low price-to-sales multiple reflects substantial market discounting in light of heavily negative cash flow yields and absent profitability metrics.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- Price / Sales
- 0.1x
- EV / EBITDA
- Data unavailable
- FCF Yield
- -1332.0%
Key risks
- Severe operational losses with an operating margin of -105.8% and FCF margin of -103.2%.
- Sharp deterioration in earnings with EPS contracting -611% year-over-year.
- Persistent downward price momentum with the stock trading 76.3% below its 200-day SMA.
Market cap $529,876.26 · data as of 2026-08-19
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze IVF with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.